1.
Clin Med (Lond)
; 23(Suppl 6): 105, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38182199
2.
Diabetes Metab Syndr
; 16(12): 102658, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36371968
RESUMO
BACKGROUND AND AIMS: Sodium-glucose co-transporter-2 inhibitors (SGLT-2i) are associated with diabetic ketoacidosis (DKA), however limited case series are published. METHODS: We evaluated the characteristics of patients admitted with SGLT-2i associated DKA. RESULTS: Over 4 months, 22 patients were identified; 45.5% of DKA was not associated with concurrent illness. CONCLUSION: DKA is not uncommonly associated with SGLT2i with no clear patient factors associated with severity.